DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,530.00
-170.00 (-2.98%)
At close: Jun 13, 2025, 3:30 PM KST

DongKoo Bio & Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-3,0412,03611,8126,6149,3279,140
Upgrade
Depreciation & Amortization
7,9817,2746,0285,6325,0544,506
Upgrade
Loss (Gain) From Sale of Assets
-0.98-5.980-123.891.3381.62
Upgrade
Asset Writedown & Restructuring Costs
665.56665.56--0-
Upgrade
Loss (Gain) From Sale of Investments
-3,987-7,119-2,0778,869-1,090-1,985
Upgrade
Loss (Gain) on Equity Investments
13,77513,112660.61-118.281,733-726.96
Upgrade
Stock-Based Compensation
243.76251.89224.51---
Upgrade
Provision & Write-off of Bad Debts
-89.11-193.35-52.8240.44241.761,370
Upgrade
Other Operating Activities
-2,3922,2951,697331.91638.041,744
Upgrade
Change in Accounts Receivable
433.42478.4-1,333-2,8611,4311,532
Upgrade
Change in Inventory
-7,379-6,632-12,838-6,686-1,897-7,192
Upgrade
Change in Accounts Payable
4,5514,389-3,0932,7152,399-2,040
Upgrade
Change in Other Net Operating Assets
565.98793.422,5582,40465.11,058
Upgrade
Operating Cash Flow
11,32517,3443,58516,81917,9037,489
Upgrade
Operating Cash Flow Growth
-0.72%383.75%-78.68%-6.05%139.06%-21.23%
Upgrade
Capital Expenditures
-13,160-21,866-13,845-4,978-4,266-5,268
Upgrade
Sale of Property, Plant & Equipment
160.66300.4411.97-
Upgrade
Sale (Purchase) of Intangibles
-3,637-3,598-2,034-6,098-1,137-192.72
Upgrade
Investment in Securities
-20,522-18,43311,851-16,2876,202-6,072
Upgrade
Other Investing Activities
134.67583.28-10639-366.43-1,059
Upgrade
Investing Cash Flow
-38,882-45,033-5,133-27,014463.93-12,564
Upgrade
Short-Term Debt Issued
-47,0297,50015,00070.7510,000
Upgrade
Long-Term Debt Issued
-9,8951,447---
Upgrade
Total Debt Issued
65,41756,9248,94715,00070.7510,000
Upgrade
Short-Term Debt Repaid
--13,528----6,883
Upgrade
Long-Term Debt Repaid
--935.5-1,126-5,966-742.12-2,536
Upgrade
Total Debt Repaid
-19,680-14,463-1,126-5,966-742.12-9,419
Upgrade
Net Debt Issued (Repaid)
45,73742,4617,8219,034-671.37581.47
Upgrade
Repurchase of Common Stock
-4,318-3,408-79.9-2,995-1,998-
Upgrade
Dividends Paid
-3,313-3,313-3,038-2,804-942.94-942.92
Upgrade
Other Financing Activities
1,3261,45449-50-76.10
Upgrade
Financing Cash Flow
39,43237,1944,7523,185-3,688-361.45
Upgrade
Foreign Exchange Rate Adjustments
84.32154.83-4.74-33.91-2.27-23.18
Upgrade
Miscellaneous Cash Flow Adjustments
0--0-0-0
Upgrade
Net Cash Flow
11,9599,6603,199-7,04314,676-5,460
Upgrade
Free Cash Flow
-1,834-4,522-10,26011,84113,6372,221
Upgrade
Free Cash Flow Growth
----13.16%514.06%-74.46%
Upgrade
Free Cash Flow Margin
-0.75%-1.81%-4.76%6.07%8.79%1.59%
Upgrade
Free Cash Flow Per Share
-67.51-165.59-371.44426.63482.5778.50
Upgrade
Cash Interest Paid
3,2052,8281,672902.19362.76401.35
Upgrade
Cash Income Tax Paid
3,7192,7754,1043,0761,392730.99
Upgrade
Levered Free Cash Flow
-9,376-9,684-15,354-140.4310,027-
Upgrade
Unlevered Free Cash Flow
-7,338-7,875-14,254509.1410,286-
Upgrade
Change in Net Working Capital
5,176-2,19313,6854,571-5,549-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.